FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma

doi:10.3748/wjg.v21.i1.196

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9303)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

766

WORD

377

HTML

5397

Figures (1-5)

206

Tables (1-3)

177

Sum=6923

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1134

Download

1246

Sum=2380

Jan 7, 2015 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (53)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jan 7, 2015; 21(1): 196-213
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.196

Table 1 Clinicopathologic characteristics of the 172 hepatocellular carcinoma patients n (%)

Characteristic	Patients
Gender
Male	116 (67)
Female	56 (33)
Age (yr)
≤ 50	73 (42)
> 50	99 (58)
Underlying liver disease
HBV	133 (77)
Others	39 (23)
Liver function (Child-Pugh classification)
Grade A	157 (91)
Grade B	11 (6)
Grade C	4 (3)
Preoperative AFP level
≤ 200 ng/mL	66 (38)
> 200 ng/mL	90 (52)
Missing data	16 (10)
Tumor size
≤ 8 cm	116 (67)
> 8 cm	51 (30)
Undetermined	5 (3)
Tumor number
≤ 3	157 (91)
> 3	15 (9)
Cirrhotic background
No	39 (23)
Yes	133 (77)
Macrovascular invasion
No	149 (87)
Yes	23 (13)
Tumor differentiation
G1/G2	154 (90)
G3	10 (6)
Undetermined	8 (4)
TNM stage
Stage I + II	135 (78)
Stage III (IIIA+IIIB+IIIC)	37 (22)

HBV: Hepatitis B virus; AFP: α-fetoprotein; TNM: Tumor-nodes-metastasis.

Table 2 Correlation between forkhead box protein M1 and E-cadherin expression and clinicopathological characteristics of hepatocellular carcinoma patients n (%)

Variable	Patients	FOXM1 expression		P-value	E-cadherin expression		P-value
Variable	Patients	Low	High	P-value	Low	High	P-value
Gender
Male	116 (67)	48 (41)	68 (59)	0.185	73 (63)	43 (37)	0.187
Female	56 (33)	17 (30)	39 (70)	0.185	29 (52)	27 (48)
Age (yr)
≤ 50	73 (42)	24 (33)	49 (67)	0.270	42 (58)	31 (42)	0.754
> 50	99 (58)	41 (41)	58 (59)	0.270	60 (61)	39 (39)
Underlying liver disease
HBV	133 (69)	51 (38)	82 (62)	0.852	80 (60)	53 (40)	0.713
Others	39 (31)	14 (36)	25 (64)	0.852	22 (56)	17 (44)
Liver function (Child-Pugh classification)
Grade A	157 (91)	59 (38)	98 (62)	0.720	93 (59)	64 (41)	0.913
Grade B	11 (6)	4 (36)	7 (64)		7 (64)	4 (36)
Grade C	4 (3)	2 (50)	2 (50)		2 (50)	2 (50)
Preoperative AFP level
≤ 200 ng/mL	66 (42)	19 (29)	47 (71)	0.095	40 (61)	26 (39)	0.330
> 200 ng/mL	90 (58)	38 (42)	52 (58)	0.095	47 (52)	43 (48)
Tumor size
≤ 8 cm	116 (69)	52 (45)	64 (55)	0.002^a	71 (61)	45 (39)	0.611
> 8 cm	51 (31)	10 (20)	41 (80)	0.002^a	29 (57)	22 (43)
Tumor number
≤ 3	157 (91)	64 (40)	93 (60)	0.010^a	95 (61)	62 (39)	0.410
> 3	15 (9)	1 (7)	14 (93)	0.010^a	7 (47)	8 (53)
Cirrhotic background
No	39 (23)	11 (28)	28 (72)	0.191	18 (46)	21 (54)	0.066
Yes	133 (77)	54 (41)	79 (59)	0.191	84 (63)	49 (37)
Macrovascular invasion
No	149 (87)	63 (42)	86 (58)	0.002^a	82 (55)	67 (45)	0.003^a
Yes	23 (13)	2 (9)	21 (91)	0.002^a	20 (87)	3 (13)
Tumor differentiation
G1/G2	154 (94)	56 (34)	98 (66)	0.502	87 (56)	67 (44)	0.047^a
G3	10 (6)	5 (80)	5 (20)	0.502	9 (90)	1 (10)
TNM stage
Stage I + II	135 (78)	58 (43)	77 (57)	0.008^a	73 (53)	62 (47)	0.008^a
Stage III (IIIA+IIIB+IIIC)	37 (22)	7 (19)	30 (81)	0.008^a	29 (78)	8 (22)

^aP < 0.05. HBV: Hepatitis B virus; AFP: α-fetoprotein; TNM: Tumor-nodes-metastasis; FoxM1: Forkhead box protein M1.

Table 3 Univariate and multivariate analyses of factors associated with survival of hepatocellular carcinoma patients

Variable	P-value
	Univariate analysis		Multivariate analysis
	RFS P-value	OS	RFS P-value	OS P-value
Gender (male vs female)	0.152	0.331	-	-
Age ( ≤ 50 yr vs > 50 yr)	0.478	0.663	-	-
Underlying disease (HBV vs others)	0.461	0.859	-	-
Liver function (A/B vs C)	0.764	0.493	-	-
Preoperative AFP level ( ≤ 200 ng/mL vs > 200 ng/mL)	0.179	0.228	-	-
Tumor size ( ≤ 8 cm vs > 8 cm)	< 0.002^a	0.012^a	0.174	0.391
Tumor number ( ≤ 3 vs > 3)	0.002^a	0.015^a	0.228	0.348
Cirrhotic background (no vs yes)	0.172	0.373	-	-
Macrovascular invasion (no vs yes)	< 0.001^a	< 0.001^a	< 0.001^a	0.003^a
Tumor differentiation (G1/G2 vs G3)	0.131	0.179	-	-
TNM stage (I/II vs III)	< 0.001^a	0.006^a	0.013^a	0.011^a
FOXM1 expression (low vs high)	0.004^a	0.007^a	0.012^a	0.008^a

^aP < 0.05. HBV: Hepatitis B virus; AFP: α-fetoprotein; TNM: Tumor-nodes-metastasis; FoxM1: Forkhead box protein M1; OS: Overall survival; RFS: Relapse-free survival.

Citation: Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. World J Gastroenterol 2015; 21(1): 196-213
URL: https://www.wjgnet.com/1007-9327/full/v21/i1/196.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i1.196